1. Home
  2. AVTX vs PED Comparison

AVTX vs PED Comparison

Compare AVTX & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • PED
  • Stock Information
  • Founded
  • AVTX 2011
  • PED N/A
  • Country
  • AVTX United States
  • PED United States
  • Employees
  • AVTX N/A
  • PED N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • AVTX Health Care
  • PED Energy
  • Exchange
  • AVTX Nasdaq
  • PED Nasdaq
  • Market Cap
  • AVTX 57.4M
  • PED 48.8M
  • IPO Year
  • AVTX 2015
  • PED N/A
  • Fundamental
  • Price
  • AVTX $4.89
  • PED $0.64
  • Analyst Decision
  • AVTX Strong Buy
  • PED Strong Buy
  • Analyst Count
  • AVTX 7
  • PED 2
  • Target Price
  • AVTX $31.00
  • PED $1.63
  • AVG Volume (30 Days)
  • AVTX 82.2K
  • PED 584.5K
  • Earning Date
  • AVTX 08-11-2025
  • PED 08-13-2025
  • Dividend Yield
  • AVTX N/A
  • PED N/A
  • EPS Growth
  • AVTX N/A
  • PED 2248.88
  • EPS
  • AVTX N/A
  • PED 0.19
  • Revenue
  • AVTX $441,000.00
  • PED $40,173,000.00
  • Revenue This Year
  • AVTX N/A
  • PED N/A
  • Revenue Next Year
  • AVTX N/A
  • PED $5.99
  • P/E Ratio
  • AVTX N/A
  • PED $3.31
  • Revenue Growth
  • AVTX N/A
  • PED 30.70
  • 52 Week Low
  • AVTX $3.39
  • PED $0.47
  • 52 Week High
  • AVTX $16.00
  • PED $1.10
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 54.89
  • PED 44.12
  • Support Level
  • AVTX $4.63
  • PED $0.58
  • Resistance Level
  • AVTX $5.02
  • PED $0.64
  • Average True Range (ATR)
  • AVTX 0.27
  • PED 0.04
  • MACD
  • AVTX 0.00
  • PED -0.01
  • Stochastic Oscillator
  • AVTX 72.73
  • PED 21.28

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: